These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3872057)

  • 61. Clinical pharmacokinetics of ranitidine.
    Roberts CJ
    Clin Pharmacokinet; 1984; 9(3):211-21. PubMed ID: 6329583
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human liver plasma membrane Ca-ATPase: identification and sensitivity to calcium antagonists.
    Lotersztajn S; Mavier P; Clergue J; Dhumeaux D; Pecker F
    Hepatology; 1982; 2(6):843-8. PubMed ID: 6216195
    [No Abstract]   [Full Text] [Related]  

  • 63. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of the anti-ischaemic drug bepridil in human plasma using gas chromatography with nitrogen-sensitive detection.
    Vink J; van Hal JH; Pognat JF; Bouquet des Chaut JL
    J Chromatogr; 1983 Jan; 272(1):87-94. PubMed ID: 6601664
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of nicardipine following oral and intravenous administration in man.
    Graham DJ; Dow RJ; Freedman D; Mroszczak E; Ling T
    Postgrad Med J; 1984; 60 Suppl 4():7-10. PubMed ID: 6527979
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of bepridil on membrane currents of rabbit sinoatrial node cells.
    Kotake H; Igawa O; Miyamoto J; Hasegawa J; Kosaka T; Furuse T; Mashiba H
    Arzneimittelforschung; 1987 Apr; 37(4):424-7. PubMed ID: 3496889
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
    Bramer SL; Forbes WP; Mallikaarjun S
    Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical pharmacokinetics and metabolism of bevantolol.
    Latts JR
    Angiology; 1986 Mar; 37(3 Pt 2):221-5. PubMed ID: 2871781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.
    Balwierczak JL; Grupp IL; Grupp G; Schwartz A
    J Pharmacol Exp Ther; 1986 Apr; 237(1):40-8. PubMed ID: 2937911
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects on hemodynamics and left ventricular ejection fraction of intravenous bepridil for impaired left ventricular function secondary to coronary artery disease.
    Josephson MA; Mody T; Coyle K; Singh BN
    Am J Cardiol; 1987 Jul; 60(1):44-9. PubMed ID: 3496779
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protective effects of bepridil on calcium injury of anoxic myocytes isolated from adult rat heart ventricular muscle.
    Cruz C; Zaoui A; Berson G; Younes A
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1126-32. PubMed ID: 3498814
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Comparison of the effects of bepridil and diltiazem in Prinzmetal's angina. Crossed, randomized, double-blind study. Apropos of 14 cases].
    Ducloux G; Manouvrier J; Bajolet A; Guermonprez JL
    Ann Cardiol Angeiol (Paris); 1986 Mar; 35(3):167-72. PubMed ID: 3486625
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridil.
    Verdouw PD; Scheffer MG
    Arzneimittelforschung; 1984; 34(1):21-5. PubMed ID: 6608356
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bioavailability of digoxin: some pitfalls and problems.
    Keller F; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):549-56. PubMed ID: 23358
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of the pharmacodynamic and pharmacokinetic interaction between calcium antagonists and digoxin.
    De Vito JM; Friedman B
    Pharmacotherapy; 1986; 6(2):73-82. PubMed ID: 3520498
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetic interactions between digoxin and other drugs.
    Marcus FI
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):82A-90A. PubMed ID: 2985676
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of toremifene.
    Anttila M; Valavaara R; Kivinen S; Mäenpää J
    J Steroid Biochem; 1990 Jun; 36(3):249-52. PubMed ID: 2142247
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Uptake of bepridil into isolated ventricular myocytes. Retention by actin.
    Cramb G; Dow JW
    Biochem Pharmacol; 1983 Jan; 32(2):227-31. PubMed ID: 6603218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.